§ BIOTECHNOLOGY
USD · BiotechnologyKNSA
KINIKSA PHARMACEUTICALS INTE
USDSector · BiotechnologyBeta · 0.11
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
13F FLOW
160 increased/new, 82 decreased/exited (13F)
AC 13F Analysis
§ 04 · FUNDAMENTALS · THE BOOKS
| P/E | 54.6 | P/B | 5.51 |
| EPS (TTM) | 0.91 |
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| Fidelity Management | 6.8M | 0.0% | +315% |
| Rubric Capital Management LP | 3.8M | 1.9% | +13% |
| BAKER BROS. ADVISORS LP | 2.8M | 0.8% | ±0% |
| TANG CAPITAL MANAGEMENT LLC | 2.3M | 5.5% | ±0% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.8M | n/a | n/a |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.3M | n/a | n/a |
◇ AC INTELLIGENCE
Top institutional owners for KNSA as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER98.8% · 0 holders
OTHER0.7% · 164 holders
QUALITY / COMPOUNDER0.3% · 18 holders
DEALER / BANK0.1% · 19 holders
TACTICAL / MACRO0.0% · 4 holders
SYSTEMATIC / QUANT0.0% · 5 holders
ACTIVIST0.0% · 1 holder
PASSIVE / INDEX0.0% · 7 holders
INCOME / DEFENSIVE0.0% · 11 holders
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for KNSA in the last 180 days.
§ 08 · COVERAGE · OUR RECENT NOTES
No notes mention KNSA yet.